Skip to main content

Seed · 2026-11-17 · Healthcare

Commit Biologics raises $58.3M

69
AI Score
Amount
$58.3M
Round
Seed
Lead
Ackermans & van Haaren
HQ
Copenhagen, DK
Why it matters: Commit Biologics' €54M seed round shows investors backing a complement-based immunotherapy platform that works without T cells, a contrast to the T cell engagers and cell therapies that dominate the field.

Copenhagen-based Commit Biologics raised €54 million ($60 million) in seed funding led by Ackermans & van Haaren.

Participants:
AbbVie Ventures, M Ventures, Bioqube Ventures, Korys, Novo Holdings

Deal Dossier PRO

Pro feature
Deal Dossier for Commit Biologics

Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.

Generate dossier — Pro
Already Pro? Sign in · See plans

Figures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).

Recent Healthcare rounds

Browse all deals in the funding database →

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing